AvantiCell Science Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Employees
  • 11
  • Latest Deal Type
  • Out of Business

AvantiCell Science General Information


Developer of a cell culture technology designed to be used in drug discovery, biomedical research and natural product testing. The company's technology provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems, that are customized to meet customers' requirements, enabling customers to evaluate bio-activity or bio-safety in a wide-range of test materials, from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Gibbsyard Building
  • Auchincruive
  • Ayr KA6 5HW
  • Scotland, United Kingdom
+44 01292 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AvantiCell Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 01-Jun-2019 00000 Completed Out of Business
11. Later Stage VC 14-Aug-2017 00000 Completed Generating Revenue
10. Grant 27-Oct-2015 00.000 00000 Completed Generating Revenue
9. Grant 08-Jul-2014 00000 00000 Completed Generating Revenue
8. Later Stage VC 22-Apr-2013 00000 00000 00.000 Completed Generating Revenue
7. Grant 01-Nov-2012 00000 00000 Completed Generating Revenue
6. Grant 01-Jul-2011 00.00 00000 Completed Startup
5. Early Stage VC 01-Jan-2010 00000 00000 00.000 Completed Startup
4. Grant 01-Oct-2009 $727K Completed Startup
3. Early Stage VC 01-Feb-2009 Completed Startup
To view AvantiCell Science’s complete valuation and funding history, request access »

AvantiCell Science Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00,000 00.00 00.00 00 00.00 0.000
Ordinary 0,000 00.00 00.00 00 00.00 0.000
To view AvantiCell Science’s complete cap table history, request access »

AvantiCell Science Patents

AvantiCell Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0909355-D0 Improved cell based assay method Withdrawn 01-Jun-2009 0000000000
GB-2470722-A Culturing cells on a phosphate glass scaffold and dissolving the scaffold using a metal ion chelator Withdrawn 01-Jun-2009 0000000000
GB-0423352-D0 "control of mammary cell number" Ceased 21-Oct-2004 00000000
GB-0521554-D0 Control of mammary cell number Withdrawn 21-Oct-2004 00000000
GB-2419881-A Peptides for breast cancer treatment Withdrawn 21-Oct-2004 C07K7/06

AvantiCell Science Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial